Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

Author: Depenbrock H.   Schmelcher S.   Peter R.   Keppler B.K.   Weirich G.   Block T.   Rastetter J.   Hanauske A.-R.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.33, Iss.14, 1997-12, pp. : 2404-2410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content